Yes [idcn]    
Independent [idcn]    
Prognostic Marker [qlco]    
HEPATOCELLULAR CARCINOMA [neop]    
Yes [idcn]    
Downstream [spco]    
Target [ftcn]    
hippo signaling pathway [celf]    
Recently [tmco]    
Link [inpr]    
Hepatocarcinogenesis [neop]    
Mouse Model [emod]    
HEPATOCELLULAR CARCINOMA [neop]    
Objective [inpr]    
CURRENT [tmco]    
Study [mnob]    
investigate [ftcn]    
Clinical Significance [fndg]    
Yes [idcn]    
HEPATOCELLULAR CARCINOMA [neop]    
Prognostic [inpr]    
Values [qlco]    
Survival [acty]    
tumor recurrence [neop]    
Methods [inpr]    
Authors [prog]    
Collected [idcn]    
Pair [qlco]    
Tumour NOS [neop]    
Adjacent [spco]    
TISSUE [tisu]    
HEPATOCELLULAR CARCINOMA [neop]    
Patients [podg]    
DEFINITIVE [tmco]    
Yes [idcn]    
Protein Expression [genf]    
Immunohistochemistry [diap]    
Western blot analysis [lbpr]    
Quantitative Polymerase chain reaction [lbpr]    
Association [menp]    
Yes [idcn]    
Chi-Square Test [inpr]    
HEPATOCELLULAR CARCINOMA [neop]    
Specific [qlco]    
Disease-Free Survival [qnco]    
Survival [acty]    
Curve [spco]    
Log [inpr]    
Rank [inpr]    
Test [lbpr]    
Regression Analyses [inpr]    
Yes [idcn]    
HEPATOCELLULAR CARCINOMA [neop]    
Performed [ftcn]    
Yes [idcn]    
majority [socb]    
HEPATOCELLULAR CARCINOMA [neop]    
Cases [ftcn]    
Approximately [qlco]    
Tumour NOS [neop]    
NUCLEUS [celc]    
Overexpression [genf]    
Yes [idcn]    
HEPATOCELLULAR CARCINOMA [neop]    
Tumour NOS [neop]    
Differentiation [celf]    
Grade [clas]    
Serum alpha-fetoprotein [lbpr]    
Regression [patf]    
Indicated [fndg]    
Yes [idcn]    
Independent [idcn]    
HEPATOCELLULAR CARCINOMA [neop]    
Specific [qlco]    
Disease-Free Survival [qnco]    
Hazard Ratio [qnco]    
CI [geoa]    
Survival [acty]    
Hazard Ratio [qnco]    
CI [geoa]    
Conclusions [idcn]    
Yes [idcn]    
Independent [idcn]    
Prognostic Marker [qlco]    
Survival [acty]    
Disease-Free Survival [qnco]    
times [tmco]    
HEPATOCELLULAR CARCINOMA [neop]    
Patients [podg]    
Tumour NOS [neop]    
Differentiation [celf]    
SERUM [bdsu]    
Therapeutic [topp]    
Target [ftcn]    
aggressive Malignancy [neop]    
CANCER [neop]    
American Cancer Society [pros]    
